Pier Capital’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.96M Sell
33,051
-279
-0.8% -$30.3K 0.66% 74
2026
Q1
$3.08M Sell
33,330
-575
-2% -$57.7K 0.51% 87
2025
Q4
$3.46M Sell
33,905
-72,315
-68% -$6.47M 0.55% 87
2025
Q3
$6.64M Buy
106,220
+33,818
+47% +$1.84M 1.04% 45
2025
Q2
$3.77M Sell
72,402
-50,555
-41% -$2.26M 0.57% 82
2025
Q1
$5.24M Sell
122,957
-107,323
-47% -$4.63M 0.88% 61
2024
Q4
$7.04M Buy
230,280
+71,851
+45% +$2.02M 1% 63
2024
Q3
$3.63M Buy
158,429
+42,575
+37% +$1.21M 0.51% 94
2024
Q2
$3.35M Buy
+115,854
New +$2.7M 0.5% 93
2020
Q4
Sell
-45,416
Closed -$5.08M 121
2020
Q3
$5.08M Sell
45,416
-733
-2% -$67.1K 0.74% 82
2020
Q2
$3.74M Sell
46,149
-17,656
-28% -$1.42M 0.6% 92
2020
Q1
$4.44M Buy
63,805
+16,103
+34% +$1.24M 0.98% 51
2019
Q4
$3.73M Sell
47,702
-22,360
-32% -$1.61M 0.61% 83
2019
Q3
$4.47M Sell
70,062
-6,455
-8% -$569K 0.76% 75
2019
Q2
$6.61M Buy
76,517
+27,323
+56% +$2.09M 1.02% 60
2019
Q1
$3.77M Sell
49,194
-84,999
-63% -$4.71M 0.59% 90
2018
Q4
$5.04M Buy
+134,193
New +$4.94M 1% 60

Other funds holding GH

Pier Capital's GH Position: Q2 2026 in Review

Pier Capital reduced its Guardant Health (GH) stake by 0.84% in Q2 2026, selling an estimated $30.3K and leaving 33,051 shares worth $4.96M. The position accounts for 0.66% of the portfolio, ranked #74.

Pier Capital first reported a position in GH in Q4 2018 and has held it in 17 quarters since. The position peaked at $7.04M in Q4 2024. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Pier Capital held 33,051 shares of Guardant Health worth $4.96M as of Q2 2026.
  • Pier Capital sold 279 Guardant Health shares in Q2 2026, an estimated $30.3K.
  • Guardant Health made up 0.66% of Pier Capital's portfolio in Q2 2026, its #74 holding.
  • Pier Capital first reported a position in Guardant Health in Q4 2018 and has held it in 17 quarters since.
  • Pier Capital's Guardant Health position peaked at $7.04M in Q4 2024.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Pier Capital's 13F filing for Q2 2026, filed 5 Aug 2026.